Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Development of chemo−/radioresistance is a major challenge for the current prostate cancer (CaP) therapy. We have previously demonstrated that epithelial cell adhesion molecule (EpCAM) is associated with CaP growth and therapeutic resistance in vitro, however, the role of EpCAM in CaP in vivo is not fully elucidated. | Epithelial cell adhesion molecule EpCAM is involved in prostate cancer chemotherapy radiotherapy response in vivo